Neuroguide ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 4.4% 6.0% 4.4% 7.5%  
Credit score (0-100)  0 45 38 46 33  
Credit rating  N/A BBB BBB BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 1,086 1,158 1,307 1,255  
EBITDA  0.0 366 238 352 62.8  
EBIT  0.0 366 238 352 62.8  
Pre-tax profit (PTP)  0.0 358.2 226.4 352.1 62.7  
Net earnings  0.0 279.0 174.9 273.8 48.6  
Pre-tax profit without non-rec. items  0.0 358 226 352 62.7  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 1,111 1,007 1,106 454  
Interest-bearing liabilities  0.0 0.0 4.2 4.2 124  
Balance sheet total (assets)  0.0 1,572 1,164 1,385 756  

Net Debt  0.0 -964 -864 -1,200 38.3  
 
See the entire balance sheet

Volume 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 1,086 1,158 1,307 1,255  
Gross profit growth  0.0% 0.0% 6.6% 12.8% -3.9%  
Employees  0 1 2 2 2  
Employee growth %  0.0% 0.0% 100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 1,572 1,164 1,385 756  
Balance sheet change%  0.0% 0.0% -26.0% 19.0% -45.4%  
Added value  0.0 366.1 238.0 352.1 62.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 33.7% 20.5% 26.9% 5.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 23.3% 17.4% 27.6% 5.9%  
ROI %  0.0% 33.0% 22.4% 33.2% 7.4%  
ROE %  0.0% 25.1% 16.5% 25.9% 6.2%  

Solidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  0.0% 81.5% 86.5% 79.8% 60.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -263.4% -363.1% -340.7% 61.0%  
Gearing %  0.0% 0.0% 0.4% 0.4% 27.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 551.0% 0.4% 0.1%  

Liquidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 6.2 7.3 4.9 1.6  
Current Ratio  0.0 3.4 7.3 4.9 2.4  
Cash and cash equivalent  0.0 964.2 868.3 1,204.0 85.9  

Capital use efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 1,090.3 986.2 1,085.1 433.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 366 119 176 31  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 366 119 176 31  
EBIT / employee  0 366 119 176 31  
Net earnings / employee  0 279 87 137 24